IVeyong pharma yaya kwi-22 ye-China china 2024

Ukusukela nge-19 kaJuni ukuya kwi-21, i-22 ye-22 ye-China kunye ne-17 ye-PMEC China yayiqhutywa kwiziko elitsha lamanye amazwein Shanghai. Li jianjie, umphathi jikelele weVeyongI-pharma, inkxaso-mali yeLimmarmaceuticals, Dr. Li Linhu, uSekela Mlawuli we-R & D Sunds, i-gie fermjun, umlawuli we-LI GIEQUS, UMPHATHISWE WENKONZO YENKONZO YAMAZWEVeyongU-pharma, noChen Lusheng, UMlawuli weSebe loLawulo lweNgeceko, waya kumboniso kwiqela lentengiso yamanye amazwe.

EBooth E220,VeyongI-pharma ibonisiweivermetin, abai-mectin, timulin fimbate, I-Eprincerinkunye nezinye iimveliso kwiabathengikumhlaba jikelele. Iimveliso eziphambili zenkampani zidlule i-US FDA kunye ne-EU CIPS kwaye zangenisa imarike yesiphelo esiphezulu sehlabathi. Ubume bayo bematrix egqibeleleyo, umgangatho wemveliso ethembekileyo kunye neentlobo zemveliso ezityebileyo zibabalwe ngabantu abaninzi.

Indawo yomboniso yayizele ngabantu. Iqela lokuthengisa lezizwe labantu ligcwele ngokupheleleyo, lalinotshintshiselwano olunamacala aphezulu abatyeleli, baphulaphule ngononophelo kwiimfuno zabathengi, kwaye banika iimpendulo zobungcali, bebonisa amandla abalulekileyo eVeyongkwimarike yehlabathi, kwaye usekwe unxibelelwano olubanzi nabathengi abanokubakho kwisiza.

Lo mboniso uphelileVeyongIindlela zokuthengisa zikaPharma kwimarike yamanye amazwe kwaye ziphinda zidityaniswe negama lenkampani kunye nefuthe kwintengiso ye-API ye-API. Kwixa elizayo, inkampani iya kuqhubeka nokukhawulezisa isantya sophuhliso lweentengiso zamanye amazwe kunye nokuphucula ngakumbiVeyongImpembelelo ka-Pharma brand kunye nokhuphiswano lwentengiso kwicandelo le-apiskunye namalungiselelo.